Possible Risk Timeframe for Immune Checkpoint Inhibitor Therapy

Hassan Abushukair (Oklahoma University Stephenson Cancer Center) found myocarditis within the first month of immunotherapy predicted fatality. Triple M overlap syndrome carried the highest myocarditis fatality.